# TG Therapeutics, Inc. (TGTX)

TG Therapeutics' Briumvi shows strong patient retention, leading to analyst optimism and potential estimate raises. However, the company recently missed EPS targets.

### About TG Therapeutics, Inc.
TG Therapeutics, Inc. is a biopharmaceutical company focused on treatments for B-cell malignancies and autoimmune diseases.  
TG Therapeutics, Inc. uses the ticker $TGTX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- TG Therapeutics, Inc. (TGTX) market dominance near a 52-week low at [-------].
- TG Therapeutics, Inc. (TGTX) Galaxy Score™ is up 32.5% from the previous week.
- TG Therapeutics, Inc. (TGTX) mentions is up 65.05% from the previous month.
- TG Therapeutics, Inc. (TGTX) posts created is up 207.69% from the previous week.

### Price: $28.50
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$tgtx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$tgtx/time-series/close.tsv)  
The current price action is a reaction to a mixed earnings report, with social posts indicating a potential rebound due to strong patient retention for Briumvi and analyst optimism, despite a missed EPS target. Some posts suggest the stock is undervalued.  

24-Hour: -0.52%
7-Day: -0.87%
30-Day: -6.77%

1-Year High: $45.50 on 2025-04-30  
1-Year Low: $26.40 on 2025-08-11  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$tgtx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$tgtx/time-series/alt_rank.tsv)  
TG Therapeutics, Inc. (TGTX) is currently AltRank #732 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +264  
[--] Month: [---] +113  
[--] Months: [---] +478  
[--] Year: [---] +712  
1-Year High: [-----] on 2026-02-05  
1-Year Low: [--] on 2025-03-03  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$tgtx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$tgtx/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +13  
[--] Month: [--] +7  
[--] Months: [--] [---]  
[--] Year: [--] +10  
1-Year High: [--] on 2025-03-14  
1-Year Low: [--] on 2025-12-09  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$tgtx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$tgtx/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [------] -13%  
[--] Month: [-------] -26%  
[--] Months: [---------] -74%  
[--] Year: [----------] +11%  
1-Year High: [-------] on 2025-05-05  
1-Year Low: [-----] on 2025-12-14  

Engagements by network (24h):
X: [-----]
News: [---]
Reddit: [--]
YouTube: [--]
TikTok: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$tgtx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$tgtx/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] +40%  
[--] Month: [-----] +65%  
[--] Months: [-----] -14%  
[--] Year: [------] +27%  
1-Year High: [---] on 2025-08-13  
1-Year Low: [--] on 2025-12-21  

Mentions by network (24h):
X: [---]
News: [--]
Reddit: [--]
YouTube: [--]
TikTok: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$tgtx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$tgtx/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning TG Therapeutics, Inc. (TGTX) in the last [--] hours which is down 16% from [--] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] +8%  
[--] Month: [---] +37%  
[--] Months: [-----] -42%  
[--] Year: [-----] +47%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-12-21  

The most influential creators that mention TG Therapeutics, Inc. in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@assaf_elharby](/creator/twitter/assaf_elharby)     | [--]    | [-----]     | [--]    | [-----]       |
| [@LayanAhmed5637](/creator/twitter/LayanAhmed5637)   | [--]    | [--]        | [--]     | [---]         |
| [@zipjet](/creator/twitter/zipjet)                   | [--]    | [-----]     | [--]     | [---]         |
| [@Tdawl01](/creator/twitter/Tdawl01)                 | [--]    | [--]        | [--]     | [---]         |
| [@stocket_rocket](/creator/twitter/stocket_rocket)   | [--]    | [--]        | [--]     | [--]          |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]     | [--]          |
| [@BehroozNajafi](/creator/twitter/BehroozNajafi)     | [--]    | [---]       | [--]     | [--]          |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [--]          |
| [@Aboyosef45](/creator/twitter/Aboyosef45)           | [--]    | [--]        | [--]     | [--]          |
| [@biopharmacaster](/creator/twitter/biopharmacaster) | [--]   | [-----]     | [--]     | [--]          |

[View More](/list/creators/$tgtx/100)
  
  
### Sentiment: 36%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$tgtx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$tgtx/time-series/sentiment.tsv)  
Current Value: 36%  
Daily Average: 75%  
[--] Week: 50% -31%  
[--] Month: 32% -52%  
[--] Months: 32% -53%  
[--] Year: 32% -32%  
1-Year High: 98% on 2025-07-08  
1-Year Low: 25% on 2026-02-01  

Most Supportive Themes:
- Briumvi Patient Retention: (35%) Positive data regarding Briumvi's patient retention rates, exceeding expectations and aligning with industry benchmarks.
- Azer-cel Car-T Therapy: (25%) Positive developments and data related to the Azer-cel Car-T therapy, indicating progress in its development and potential.
- Analyst Optimism: (15%) Analysts express positive sentiment towards TG Therapeutics, with buy ratings and increased price targets reflecting confidence in the company's future.
  
Most Critical Themes:
- EPS Miss: (10%) The company missed analyst expectations for Earnings Per Share (EPS) in the recent quarter, raising concerns about profitability despite revenue growth.
  
  
  
### Social Dominance: 0.0077%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$tgtx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$tgtx/time-series/social_dominance.tsv)  
Current Value: 0.0077%  
Daily Average: 0.025%  
[--] Week: 0.00777% -0.00133%  
[--] Month: 0.017% -0.0076%  
[--] Months: 0.017% -0.012%  
[--] Year: 0.017% -0.024%  
1-Year High: 0.108% on 2025-03-05  
1-Year Low: 0.0041% on 2025-10-24  
  
  
### Market Dominance: 0.00513%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$tgtx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$tgtx/time-series/market_dominance.tsv)  
Current Value: 0.00513%  
Daily Average: 0%  
1-Year High: 0.235% on 2025-04-07  
1-Year Low: 0.00511% on 2026-01-12  
  
  
### Market Cap: $4,524,644,354
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$tgtx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$tgtx/time-series/market_cap.tsv)  
Current Value: $4,524,644,354  
Daily Average: $5,325,260,309  
[--] Week: $4,508,768,408 +2.10%  
[--] Month: $4,524,644,354 -6.80%  
[--] Months: $4,524,644,354 +2.10%  
[--] Year: $4,524,644,354 -1.30%  
1-Year High: $7,225,909,231 on 2025-04-30  
1-Year Low: $4,187,185,527 on 2025-08-11  

### Top TG Therapeutics, Inc. News
Top news links shared on social in the last [--] hours  

*Showing a maximum of [--] news posts without a LunarCrush subscription.*  

"TG Therapeutics: Estimates Could Soon Be Raised Again (NASDAQ:TGTX) Seeking Alpha TGTherapeutics is on track to beat expectations with Briumvi its fast-growing best-in-class MS treatment. Find out why TGTX stock is a Buy"  
[News Link](https://seekingalpha.com/article/4790390-tg-therapeutics-estimates-could-soon-be-raised-again) [@SeekingAlpha](/creator/x/SeekingAlpha) 2025-05-28T10:00Z 316.4K followers, [----] engagements



### Top TG Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"👌 $SMCI/ $SONN / $TGTX/ $KAPA  💥👌 $SPX $LCID $BTS $NVDA $TSLA $NCNA $HIMS $MULN $HOLO $PHH $ABVE $GNS $HOTH $SMCI $RXRX $FLNC $CENN $PTHL $NAOV $RKLB $YOUL $META"  
[X Link](https://x.com/rabeaeee800/status/2023148139117416578) [@rabeaeee800](/creator/x/rabeaeee800) 2026-02-15T21:31Z [--] followers, [---] engagements


"$LRHC La Rosa Holdings Corp. Signs Contract to Acquire Development Site for Up to [-----] Sq. Ft. Tier III AI Data Center in Central Floridas Fastest-Growing Region $TGTX $VKTX $META $DJT $APLD $TSLA $SPY $NVDA $HOLO $TNXP $TSLA $DRCT $NVDA https://www.stocktitan.net/news/LRHC/la-rosa-holdings-corp-signs-contract-to-acquire-development-site-for-rpfxspg61695.html https://www.stocktitan.net/news/LRHC/la-rosa-holdings-corp-signs-contract-to-acquire-development-site-for-rpfxspg61695.html"  
[X Link](https://x.com/TradesProfits/status/2023102144120021377) [@TradesProfits](/creator/x/TradesProfits) 2026-02-15T18:28Z [---] followers, [---] engagements


"👍 $DVLT $UOKA $QBTS $BATL $OFAL $STSS $GLE $MASK $OTLK $NAMI $GOOGL $DIS $MARA $PTON $MELI $NET $TGTX $TEM $SOUN $NVO $TSLA $GOOG $WIFI $TRUMP #USA"  
[X Link](https://x.com/anyuser/status/2022992819066195987) [@undefined](/creator/x/undefined) 2026-02-15T11:14Z [--] followers, [---] engagements


"$FGL       31$ [-----]  220% $DVLT $UOKA $QBTS $BATL $OFAL $STSS $GLE $MASK $OTLK $NAMI $GOOGL $DIS $MARA $PTON $MELI $NET $TGTX $TEM $SOUN $NVO $TSLA $GOOG $WIFI $TRUMP #USA"  
[X Link](https://x.com/assaf_elharby/status/2022975888434880986) [@assaf_elharby](/creator/x/assaf_elharby) 2026-02-15T10:06Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing